Park Square Executive Search

2017 Search Placements & Industry News

Threat Stack Announces Jonaki Egenolf as CMO

Threat Stack, provider of the industry’s most comprehensive intrusion detection platform for cloud, hybrid-cloud, and on-premise environments, today announced two major additions to its leadership team. Jonaki Egenolf has been named the company’s first Chief Marketing Officer, while Chris Ford joins as Vice President of Product. 

Melinta Therapeutics Announces Successful Completion of Merger

Melinta Therapeutics Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced that concurrent with the closing of the merger, the board will add Jay Galeota, a pharmaceutical veteran who has held diverse key leadership positions including chief strategy and business development officer and president, emerging businesses at Merck & Co. Inc., and who is currently the president and chief operating officer of G&W Laboratories, Inc. 

Interactions Announces Robert Nagle as Chief Technology Officer and Chief Product Officer

Interactions, LLC, a leading provider of Intelligent Virtual Assistants (IVAs) for enterprise customer care, today announced Robert Nagle has joined the company as Chief Technology Officer and Chief Product Officer.

Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company

Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial infections, and Cempra, Inc. (Nasdaq:CEMP) today announced that their joint chief executive officer (CEO) selection committee has selected Dan Wechsler to be president and CEO and a member of the board of directors of the combined company.

Colt hires ex-Windstream and XO exec Randy Nicklas

Colt has appointed Randy Nicklas, former CTO of XO Communications and then Windstream in the US, as its vice president of network engineering.

Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer

Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer.

Revolution Growth Adds New Partner Todd Klein, Promotes Steve Murray to Managing Partner, Names Evan Morgan Special Partner

Today Revolution Growth, Revolution’s growth-stage investment fund launched by Steve Case, Ted Leonsis, and Donn Davis, announced further expansion of its team following the closing of its $525 million Revolution Growth III fund last year. The changes include the addition of a new Partner, Todd Klein; the promotion of Steve Murray to Managing Partner and Evan Morgan to Special Partner; and the addition of Luisa Sucre as Analyst.

Cognoa Hires Vice President of Medical, Further Advancing Developmental Diagnosis Technology

Sharief Taraman, MD, joins Cognoa as vice president of medical, bringing experience in pediatric neurology and leading Cognoa's healthcare and data science expansion.

Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer

Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced the appointment of Donald Haut, Ph.D. as its Chief Business Officer. 

Neil Guterman Named Dean of The Silver School of Social Work

NYU President Andrew Hamilton and Provost Katherine E. Fleming today named Neil Guterman, a nationally recognized expert on child abuse and neglect and child victimization, as dean of NYU's Silver School of Social Work, effective September 1, 2017.

Zymergen Enhances R&D Leadership with Key Hires

Zymergen, Inc., a technology company focused on leveraging automation and computational tools to engineer microbes, has hired several new senior staff to lead and continue to develop the company’s research, development, and automation functions. These key additions are: David McLoughlin, Ph.D., Vice President of Automation; Jeff Touchman, Ph.D., Vice President of Metabolic Engineering; and Vytas SunSpiral, Director of Advanced Technology. 

Brodl Named Provost at Illinois Wesleyan University

Mark Brodl, currently Associate Vice President for Academic Affairs: Budget and Research at Trinity University in San Antonio, Texas, has been named the next provost of Illinois Wesleyan University, effective July 17.

Continuous positive compensation trends indicate a healthy private life sciences sector

Data on executive target cash compensation for non-founders, from a 2016 survey of US-based private life sciences companies, reveal a 4.2% year-over-year rise following a 3.3% increase in 2015 and a 3% increase in 2014. The data points to consistent 'compensation inflation', according to CompStudy, which they believe more appropriately describes year-over-year movement. 

Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today announced the appointment of Christopher Wright, M.D., MMSc., Ph.D., as senior vice president of global development and chief development officer. 

Christopher Morphew named dean of Johns Hopkins School of Education

Morphew, now executive associate dean for research and innovation at the University of Iowa College of Education, will join Johns Hopkins on Aug. 1. 

Merck & Co. Appoints Dean Y. Li, M.D., Ph.D. as Vice President, Head of Translational Medicine

Merck & Co. has appointed Dean Y. Li, M.D., Ph.D. as Vice President, Head of Translational Medicine. Li most recently served as the H.A. & Edna Benning Professor of Medicine and Cardiology at the University of Utah, as the Vice-Dean of research at the University of Utah Health Science Center, and as the Chief Scientific Officer of University of Utah Health Care.

Reverend Scott R. Pilarz, S.J., To Serve Again As President Of The University Of Scranton

The University of Scranton’s 24th president, Rev. Scott R. Pilarz, S.J., ’H15 will return to Scranton to serve as the Jesuit University’s president again. Lawrence R. Lynch, chair of the University’s Board of Trustees, made the announcement to the University community today. Father Pilarz will succeed Kevin. P. Quinn, S.J., whose term as president ends in June at the close of the 2016-17 academic year.

Hofstra announces new Dean of Liberal Arts and Sciences

Hofstra University President Stuart Rabinowitz announced the appointment of Dr. Benjamin Rifkin, professor of modern languages and literature at Ithaca College, as the new Dean of the Hofstra College of Liberal Arts & Sciences. 

CompStudy Webinar REPLAY: Executive Compensation & Team Composition

Thank you to those who participated in our February 3 CompStudy Technology and Life Sciences webinars: Executive Compensation & Team Composition: Attracting and Retaining the Best and Brightest to Your Team. Below you will find links to the presentation materials.

Presentation Slides  |  Webinar Recording

Life Sciences
Presentation Slides  |  Webinar Recording

Linda Hall Library Appoints Jane Davis as Vice President for Access and Digital Services

Linda Hall Library has appointed Jane Davis as Vice President for Access and Digital Services.

An Open Letter to the BioPharma Community

On January 11, 2017, more than 100 life sciences industry leaders outlined guiding principles and best practices to improve gender diversity throughout industry.

Stephens appointed university librarian

Denise Stephens, university librarian at the University of California, Santa Barbara (UCSB), has been appointed vice provost and university librarian at Washington University in St. Louis, effective July 1, according to Provost Holden Thorp. Stephens succeeds Jeffrey G. Trzeciak, who left the university last July.

Medical Technology: What Changing Venture Capital Investments Signal

The market for medical devices historically has been dominated by big-ticket “physician preference items” such as artificial joints, spinal implants, and cardiac pacemakers. Venture capital and private equity investors have been eager to fund new firms in this expanding and lucrative domain. Changes in physician payment and organization are reducing the demand for these cost-increasing innovations, however, and redirecting the flow of investment capital.